Xiaohong Yu

1.6k total citations
58 papers, 1.2k citations indexed

About

Xiaohong Yu is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Hematology. According to data from OpenAlex, Xiaohong Yu has authored 58 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Cardiology and Cardiovascular Medicine, 13 papers in Molecular Biology and 10 papers in Hematology. Recurrent topics in Xiaohong Yu's work include Atrial Fibrillation Management and Outcomes (11 papers), Cardiac Arrhythmias and Treatments (9 papers) and Hematopoietic Stem Cell Transplantation (7 papers). Xiaohong Yu is often cited by papers focused on Atrial Fibrillation Management and Outcomes (11 papers), Cardiac Arrhythmias and Treatments (9 papers) and Hematopoietic Stem Cell Transplantation (7 papers). Xiaohong Yu collaborates with scholars based in China, United States and Serbia. Xiaohong Yu's co-authors include Fashui Hong, Yu‐Qing Zhang, Lei Sheng, Jie Hong, He Huang, Xiaoyang Zhao, Zhen Cai, Nan Wu, Yuguan Ze and Qingqing Sun and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Xiaohong Yu

55 papers receiving 1.2k citations

Peers

Xiaohong Yu
Ji-Yoon Noh South Korea
Takeshi Fujisawa United Kingdom
Evguenia Arguiri United States
M. Spycher Switzerland
Ji-Yoon Noh South Korea
Xiaohong Yu
Citations per year, relative to Xiaohong Yu Xiaohong Yu (= 1×) peers Ji-Yoon Noh

Countries citing papers authored by Xiaohong Yu

Since Specialization
Citations

This map shows the geographic impact of Xiaohong Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaohong Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaohong Yu more than expected).

Fields of papers citing papers by Xiaohong Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaohong Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaohong Yu. The network helps show where Xiaohong Yu may publish in the future.

Co-authorship network of co-authors of Xiaohong Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaohong Yu. A scholar is included among the top collaborators of Xiaohong Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaohong Yu. Xiaohong Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
He, Jiakang, et al.. (2024). β-Hydroxybutyrate and Citrate Synthase as Potential Diagnostic Biomarkers in Aging-Related Atrial Fibrillation. Journal of Cardiovascular Translational Research. 18(1). 133–145. 1 indexed citations
2.
Zhang, Xinxin, Ning Wang, Fangfang Sun, et al.. (2023). Dapagliflozin Attenuates Heart Failure With Preserved Ejection Fraction Remodeling and Dysfunction by Elevating β-Hydroxybutyrate–activated Citrate Synthase. Journal of Cardiovascular Pharmacology. 82(5). 375–388. 24 indexed citations
3.
Chen, Hongli, Xiaohong Yu, Yueheng Yin, et al.. (2023). Multimorbidity patterns and the association with health status of the oldest-old in long-term care facilities in China: a two-step analysis. BMC Geriatrics. 23(1). 851–851. 9 indexed citations
4.
Zhang, Rongfeng, Xumin Guan, Yiheng Yang, et al.. (2022). E/E′ Is a New Independent Predictor of Recovered Ejection Fraction in Patients With Systolic Heart Failure Undergoing Ablation for Atrial Fibrillation. Frontiers in Cardiovascular Medicine. 8. 707996–707996. 6 indexed citations
5.
Yu, Xiaohong, et al.. (2021). SAGE1: a Potential Target Antigen for Lung Cancer T-Cell Immunotherapy. Molecular Cancer Therapeutics. 20(11). 2302–2313. 9 indexed citations
6.
Xia, Yunlong, et al.. (2021). High-power, short-duration ablation in the coronary sinus: clinical cases and preliminary observations on swine hearts. Journal of Interventional Cardiac Electrophysiology. 63(2). 311–321. 1 indexed citations
8.
Zhang, Rongfeng, Yue Wang, Zhengyan Wang, et al.. (2021). Risk Stratification for Atrial Fibrillation and Outcomes in Tachycardia-Bradycardia Syndrome: Ablation vs. Pacing. Frontiers in Cardiovascular Medicine. 8. 674471–674471. 5 indexed citations
9.
Sun, Wei, et al.. (2021). Low-Level Stimulation and Ethanol Ablation of the Vein of Marshall Prevent the Vagal-Mediated AF. Frontiers in Cardiovascular Medicine. 8. 675485–675485. 2 indexed citations
10.
Yu, Xiaohong, et al.. (2020). Correlation Analysis of Helicobacter pylori Infection and Diges-tive Tract Symptoms in Children and Related Factors of Infec-tion. Iranian Journal of Public Health. 49(10). 1912–1920. 3 indexed citations
11.
Wang, Binsheng, Yongxian Hu, Shan Wei, et al.. (2017). mTOR inhibition improves the immunomodulatory properties of human bone marrow mesenchymal stem cells by inducing COX-2 and PGE2. Stem Cell Research & Therapy. 8(1). 292–292. 45 indexed citations
12.
Liu, Lizhen, Qin Yu, Kaimin Hu, et al.. (2016). Electro-Acupuncture Promotes Endogenous Multipotential Mesenchymal Stem Cell Mobilization into the Peripheral Blood. Cellular Physiology and Biochemistry. 38(4). 1605–1617. 14 indexed citations
13.
Wang, Binsheng, Yongxian Hu, Lizhen Liu, et al.. (2015). Phenotypical and Functional Characterization of Bone Marrow Mesenchymal Stem Cells in Patients with Chronic Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation. 21(6). 1020–1028. 7 indexed citations
14.
Yang, Hui, Nan Li, Lina Song, et al.. (2015). Activation of NOD1 by DAP contributes to myocardial ischemia/reperfusion injury via multiple signaling pathways. APOPTOSIS. 20(4). 512–522. 19 indexed citations
15.
Luo, Yi, Haowen Xiao, Xiaoyu Lai, et al.. (2014). T-cell-replete haploidentical HSCT with low-dose anti-T-lymphocyte globulin compared with matched sibling HSCT and unrelated HSCT. Blood. 124(17). 2735–2743. 139 indexed citations
17.
Wang, Yuefei, Fengxia Du, Hong‐Ye Zhao, et al.. (2014). Synergistic Association between Two Alcohol Metabolism Relevant Genes and Coronary Artery Disease among Chinese Hypertensive Patients. PLoS ONE. 9(7). e103161–e103161. 7 indexed citations
18.
Yu, Xiaohong, Jun Liu, Hao Zhu, et al.. (2013). Synergistic association of DNA repair relevant gene polymorphisms with the risk of coronary artery disease in northeastern Han Chinese. Thrombosis Research. 133(2). 229–234. 21 indexed citations
20.
Xiao, Haowen, Weijie Cao, Xiaoyu Lai, et al.. (2010). Immunosuppressive Cytokine Gene Polymorphisms and Outcome after Related and Unrelated Hematopoietic Cell Transplantation in a Chinese Population. Biology of Blood and Marrow Transplantation. 17(4). 542–549. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026